Loading...
XTAI
1720
Market cap355mUSD
Jul 09, Last price  
63.90TWD
1D
0.47%
1Q
1.27%
Jan 2017
96.01%
Name

Standard Chem & Pharm Co Ltd

Chart & Performance

D1W1MN
XTAI:1720 chart
P/E
12.31
P/S
1.63
EPS
5.19
Div Yield, %
4.38%
Shrs. gr., 5y
6.22%
Rev. gr., 5y
10.28%
Revenues
7.02b
+3.44%
1,924,414,0002,011,721,0002,182,198,0002,284,616,0002,894,482,0003,332,008,0003,373,811,0003,053,983,0003,295,656,0003,321,366,0003,673,801,0003,848,684,0003,573,093,0003,937,129,0004,305,400,0004,604,082,0005,851,368,0006,239,768,0006,789,223,0007,023,025,000
Net income
928m
+5.36%
323,443,000267,715,000274,597,000293,463,000210,053,000246,748,000271,426,000298,386,000374,235,000347,894,000340,216,000363,286,000374,359,000376,482,000524,172,000706,734,0001,153,620,000834,886,000880,501,000927,659,000
CFO
1.87b
+10.05%
358,745,000323,595,000719,169,000634,227,000272,474,000405,494,000402,246,000427,259,000582,305,000650,865,000305,376,000708,738,000484,935,000637,939,000922,580,000827,034,0001,227,834,0001,336,523,0001,694,941,0001,865,237,000
Dividend
Aug 06, 20252.8 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Standard Chem & Pharm Co. Ltd. (SCP) is a Taiwanese enterprise specializing in the development, manufacturing, and commercialization of a broad spectrum of pharmaceutical products, nutritional supplements, and Active Pharmaceutical Ingredients (APIs). The company's diverse offerings include medications targeting various therapeutic areas, such as the circulatory, digestive, and respiratory systems. Their portfolio also features antihistamines, central nervous system (CNS) agents, metabolism-regulating drugs, anti-microbial treatments, and topical preparations for skin and mucous membrane conditions. Beyond finished drug products, SCP provides APIs for both human and veterinary applications, as well as various pharmaceutical excipients. Founded in 1967, Standard Chem & Pharm Co. Ltd. maintains its corporate headquarters in Tainan City, Taiwan.
URL
https://www.standard.com.tw/
IPO date
Dec 12, 1995
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT